Skip to main content

Legato Capital Management LLC

Position in SUPN — Supernus Pharmaceuticals, Inc.

CIK 1442641 San Francisco, CA

Position in SUPN

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$729,242
+$2,479 QoQ
Shares Held
14,108
-3.5% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2022
14 quarters on record

Common Shares in SUPN Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Legato Capital Management LLC holds $15,801,793 across 13 Drug Manufacturers - Specialty & Generic names. SUPN ranks #8 (4.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 SUPN
Supernus Pharmaceuticals, Inc.
This page
14,108 $729,242

All Filings in SUPN

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $729,242 14,108
2025-12-31 $726,763 14,623
2025-09-30 $1,075,179 22,498
2025-06-30 $669,012 21,225
2025-03-31 $695,118 21,225
2024-12-31 $992,013 27,434
2024-09-30 $669,496 21,472
2024-06-30 $574,376 21,472
2024-03-31 $934,784 27,405
2023-12-31 $621,399 21,472
2023-09-30 $591,983 21,472
2023-06-30 $670,608 22,309
2023-03-31 $808,255 22,309
2022-12-31 $795,762 22,309